MAKING GREAT DRUGS BETTER

News

ExSight Ventures discuss why they invested into Re-Vana

In the OIS Podcast, ExSight Ventures discuss why they invested into Re-Vana. Here is the segment where they discuss Re-Vana Therapeutics:  Download the excerpt using this link.Listen to the Full Podcast Here (Discussion of Re-Vana commences at 43 minutes.)...

read more